Data protection Impressum

Education

Harnessing the promise of emerging quantum technologies, Western Switzerland is shaping up to be a pivotal region in this transformative field.

Why Switzerland

Quantum technologies in Western Switzerland

LC3 cement, natural color on the right, with color control on the left. LC3 cement has the potential to significantly reduce global CO2 emissions.

A new material from EPFL to cut 500 million tons of emissions by 2030

21 November 2023

The inclusion of Aktiia’s technology in the GAPP study is a testament to its potential in reshaping blood pressure research.

Aktiia’s blood pressure monitoring technology advances global cardiovascular research

14 November 2023

Switzerland's commitment to fostering talent and driving forward-thinking initiatives ensures its continued leadership and influence on the global stage, making it an exemplary model for talent development and competitiveness.

Switzerland maintains top rank in 2023’s Global Talent Competitiveness Index

13 November 2023

From left to right: Christoph Ammann, Canton of Bern - Dr. med. h.c. Uwe E. Jocham, Insel Gruppe - Prof. Dr. Christian Leumann, University of Bern - Dr. Alexandre Pauchard, CSEM, Jens Krauss, CSEM.

Bern’s journey to becoming a world-class medtech hub by 2030

9 November 2023

Novochizol technology quantitatively transforms single linear chitosan molecules into cross-linked, uniformly sized nanospheres.

EPFL and Novochizol to collaborate on designing more efficient immunotherapies

2 November 2023

The Institute of Tissue Medicine and Pathology of the University of Bern covers the entire width of the morphological and molecular diagnostics of tissue samples. | © University of Bern

A new gel offers targeted relief for ulcerative colitis patients

2 November 2023

Through this partnership, the synergy between academic excellence and pioneering biotherapeutic research is set to delineate new horizons in patient care, particularly in the field of tissue regeneration and repair.

Orio Therapeutics partners with Australia’s largest University to transform regenerative medicine

10 October 2023

The Institute of Life Technologies of the HES-SO Valais/Wallis has forged a five-year collaboration with Debiopharm Research & Manufacturing to develop new targeted antibody fragment vectorization technologies.

HES-SO Valais-Wallis and Debiopharm partner up to battle cancer

4 October 2023

Through interdisciplinary research projects and real-world experimentation involving both scientists and businesses, the Smart Living Lab encompasses theory and practice for a sustainable urban future.

Shaping the future built environment at the Smart Living Lab

1 … 9 10 11 12 13 14 15 16 17 … 22